📖
CYLD: A Key Factor and Novel Predictive Biomarker of Cross-Resistance to Chemotherapy and Radiotherapy in Oral Squamous Cell Carcinoma.
Yonemaru K, Suenaga N, Masuda T, Kariya R, Seki Y, Yoshida R, Nakayama H, Kuwahara Y, Nishimura F, Oda K, Li JD, Jono H

CYLD: A Key Factor and Novel Predictive Biomarker of Cross-Resistance to Chemotherapy and Radiotherapy in Oral Squamous Cell Carcinoma.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Int J Biol Sci.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title CYLD: A Key Factor and Novel Predictive Biomarker of Cross-Resistance to Chemotherapy and Radiotherapy in Oral Squamous Cell Carcinoma.
Author / Organization Yonemaru K, Suenaga N, Masuda T, Kariya R, Seki Y, Yoshida R, Nakayama H, Kuwahara Y, Nishimura F, Oda K, Li JD, Jono H
Subject & Discipline Int J Biol Sci
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-78150
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »